Home
Conditions
Leukemia, Lymphoid

Clinical trial condition

Leukemia, Lymphoid

Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.

3,014 public trials 549 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Lymphoid trial results

Recruiting

Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

NCT06810778

Conditions: Cutaneous T-Cell Lymphoma Refractory, Disease Attributes, Hematologic Diseases, +16 more
Locations: David Geffen School of Medicine at the University of California at Los Angeles Los Angeles, California, United States

View Trial Details

Recruiting

CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma

NCT07257419

Conditions: Disease Attributes, Hematologic Diseases, Hematologic Malignancy, +17 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Recruiting

Multicenter HomeVENT: Home Values and Experiences Navigation Track

NCT06102330

Conditions: Behavior, Communication, Hematologic Diseases, +14 more
Locations: Johns Hopkins All Childrens Hospital Tampa, Florida, United States

Children's Hospital New Orleans New Orleans, Louisiana, United States

Johns Hopkins University School of Medicine Baltimore, Maryland, United States

Seattle Childrens Hospital Seattle, Washington, United States

View Trial Details

Recruiting

Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias

NCT06364423

Conditions: Acute Lymphoblastic Leukemia, B-Lymphocytic Leukemia, Chronic, B-cell Chronic Lymphocytic Leukemia, +20 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

NCT03959085

Conditions: B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Burkitt Lymphoma, +25 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

USA Health Strada Patient Care Center Mobile, Alabama, United States

Providence Alaska Medical Center Anchorage, Alaska, United States

Banner Children's at Desert Mesa, Arizona, United States

View all 231 locations

View Trial Details

Recruiting

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

NCT04301076

Conditions: Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma, Chronic Adult T-Cell Leukemia/Lymphoma, +21 more
Locations: Emory University Hospital Midtown Atlanta, Georgia, United States

Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

Siteman Cancer Center at Saint Peters Hospital City of Saint Peters, Missouri, United States

Siteman Cancer Center at West County Hospital Creve Coeur, Missouri, United States

View all 19 locations

View Trial Details

Recruiting

Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma

NCT06533748

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Novant Health Presbyterian Hemby Children's Hospital Charlotte, North Carolina, United States

Saint Francis Children's Hospital Tulsa, Oklahoma, United States

St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Recruiting

Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)

NCT00923507

Conditions: Blood Protein Disorders, CLL (Chronic Lymphocytic Leukemia), Cardiovascular Diseases, +29 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma

NCT06747910

Conditions: Childhood Cancer, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Recruiting

Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT04169737

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Leukemia, Lymphoid

Leukemia, Lymphoid trial results

Related conditions